Advanced

Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension : Obesity and heart failure

Jordan, Jens; Toplak, Hermann; Grassi, Guido; Yumuk, Volkan; Kotsis, Vasilios; Engeli, Stefan; Cuspidi, Cesare; Nilsson, Peter M. LU ; Finer, Nick and Doehner, Wolfram (2016) In Journal of Hypertension 34(9). p.1678-1688
Abstract

Obese individuals are more likely to develop heart failure. Yet, once heart failure is established, the impact of overweight and obesity on prognosis and survival is unclear. The purpose of this joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension is to provide an overview on the current scientific literature on obesity and heart failure in terms of prognosis, mechanisms, and clinical management implications. Moreover, the document identifies open questions that ought to be addressed. The need for more tailored weight management recommendations in heart failure will be emphasized and, in line with the emerging evidence, aims to distinguish between primary disease and... (More)

Obese individuals are more likely to develop heart failure. Yet, once heart failure is established, the impact of overweight and obesity on prognosis and survival is unclear. The purpose of this joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension is to provide an overview on the current scientific literature on obesity and heart failure in terms of prognosis, mechanisms, and clinical management implications. Moreover, the document identifies open questions that ought to be addressed. The need for more tailored weight management recommendations in heart failure will be emphasized and, in line with the emerging evidence, aims to distinguish between primary disease and secondary outcome prevention. In the primary prevention of heart failure, it appears prudent advising obese individuals to lose or achieve a healthy body weight, especially in those with risk factors such as hypertension or type 2 diabetes. However, there is no evidence from clinical trials to guide weight management in overweight or obese patients with established heart failure. Prospective clinical trials are strongly encouraged.

(Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
heart failure, hypertension, neurohumoral, obesity, obesity paradox
in
Journal of Hypertension
volume
34
issue
9
pages
11 pages
publisher
Lippincott Williams & Wilkins
external identifiers
  • Scopus:84982883832
ISSN
0263-6352
DOI
10.1097/HJH.0000000000001013
language
English
LU publication?
yes
id
43914174-d228-4573-865d-ae2b4ae6aceb
date added to LUP
2016-09-01 16:28:44
date last changed
2016-10-04 12:03:41
@misc{43914174-d228-4573-865d-ae2b4ae6aceb,
  abstract     = {<p>Obese individuals are more likely to develop heart failure. Yet, once heart failure is established, the impact of overweight and obesity on prognosis and survival is unclear. The purpose of this joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension is to provide an overview on the current scientific literature on obesity and heart failure in terms of prognosis, mechanisms, and clinical management implications. Moreover, the document identifies open questions that ought to be addressed. The need for more tailored weight management recommendations in heart failure will be emphasized and, in line with the emerging evidence, aims to distinguish between primary disease and secondary outcome prevention. In the primary prevention of heart failure, it appears prudent advising obese individuals to lose or achieve a healthy body weight, especially in those with risk factors such as hypertension or type 2 diabetes. However, there is no evidence from clinical trials to guide weight management in overweight or obese patients with established heart failure. Prospective clinical trials are strongly encouraged.</p>},
  author       = {Jordan, Jens and Toplak, Hermann and Grassi, Guido and Yumuk, Volkan and Kotsis, Vasilios and Engeli, Stefan and Cuspidi, Cesare and Nilsson, Peter M. and Finer, Nick and Doehner, Wolfram},
  issn         = {0263-6352},
  keyword      = {heart failure,hypertension,neurohumoral,obesity,obesity paradox},
  language     = {eng},
  month        = {09},
  number       = {9},
  pages        = {1678--1688},
  publisher    = {ARRAY(0x9eb83f8)},
  series       = {Journal of Hypertension},
  title        = {Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension : Obesity and heart failure},
  url          = {http://dx.doi.org/10.1097/HJH.0000000000001013},
  volume       = {34},
  year         = {2016},
}